189 related articles for article (PubMed ID: 25345993)
21. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
DeBarros A; Chaves-Ferreira M; d'Orey F; Ribot JC; Silva-Santos B
Eur J Immunol; 2011 Jan; 41(1):195-201. PubMed ID: 21182090
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha.
Ueta C; Kawasumi H; Fujiwara H; Miyagawa T; Kida H; Ohmoto Y; Kishimoto S; Tsuyuguchi I
Eur J Immunol; 1996 Dec; 26(12):3066-73. PubMed ID: 8977306
[TBL] [Abstract][Full Text] [Related]
23. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.
Harly C; Guillaume Y; Nedellec S; Peigné CM; Mönkkönen H; Mönkkönen J; Li J; Kuball J; Adams EJ; Netzer S; Déchanet-Merville J; Léger A; Herrmann T; Breathnach R; Olive D; Bonneville M; Scotet E
Blood; 2012 Sep; 120(11):2269-79. PubMed ID: 22767497
[TBL] [Abstract][Full Text] [Related]
24. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
[TBL] [Abstract][Full Text] [Related]
25. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
[TBL] [Abstract][Full Text] [Related]
26. Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells.
Rodrigues NV; Correia DV; Mensurado S; Nóbrega-Pereira S; deBarros A; Kyle-Cezar F; Tutt A; Hayday AC; Norell H; Silva-Santos B; Dias S
Cancer Immunol Res; 2018 Apr; 6(4):448-457. PubMed ID: 29358174
[TBL] [Abstract][Full Text] [Related]
27. Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis.
Hu C; Qian L; Miao Y; Huang Q; Miao P; Wang P; Yu Q; Nie H; Zhang J; He D; Xu R; Chen X; Liu B; Zhang D
Cell Mol Immunol; 2012 May; 9(3):245-54. PubMed ID: 22139198
[TBL] [Abstract][Full Text] [Related]
28. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
Boutin L; Scotet E
Front Immunol; 2018; 9():828. PubMed ID: 29731756
[TBL] [Abstract][Full Text] [Related]
29. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
30. Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.
Daguzan C; Moulin M; Kulyk-Barbier H; Davrinche C; Peyrottes S; Champagne E
J Immunol; 2016 Mar; 196(5):2219-29. PubMed ID: 26819204
[TBL] [Abstract][Full Text] [Related]
31. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
[TBL] [Abstract][Full Text] [Related]
32. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C
Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
[TBL] [Abstract][Full Text] [Related]
33. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
Moens E; Brouwer M; Dimova T; Goldman M; Willems F; Vermijlen D
J Leukoc Biol; 2011 May; 89(5):743-52. PubMed ID: 21330350
[TBL] [Abstract][Full Text] [Related]
34. Modulation of γδ T-cell activation by neutrophil elastase.
Towstyka NY; Shiromizu CM; Keitelman I; Sabbione F; Salamone GV; Geffner JR; Trevani AS; Jancic CC
Immunology; 2018 Feb; 153(2):225-237. PubMed ID: 28888033
[TBL] [Abstract][Full Text] [Related]
35. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.
Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I
Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744
[TBL] [Abstract][Full Text] [Related]
36. Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system.
Dieli F; Fadda R; Caccamo N
Cell Mol Immunol; 2014 Mar; 11(2):123-5. PubMed ID: 24270471
[No Abstract] [Full Text] [Related]
37. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
38. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
39. Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells.
Oberg HH; Wesch D; Kalyan S; Kabelitz D
Front Immunol; 2019; 10():1690. PubMed ID: 31379875
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of type I IFNs on the growth of WC1- CD8+ gamma delta T cells and WC1+ CD8- gamma delta T cells in vitro.
Tuo W; Bazer FW; Davis WC; Zhu D; Brown WC
J Immunol; 1999 Jan; 162(1):245-53. PubMed ID: 9886392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]